U.S. To Assign 15 FDA Inspectors To China In October
This article was originally published in PharmAsia News
Executive Summary
The U.S. government plans to assign as many as 15 inspectors to three major cities in China, beginning in October, to conduct U.S. FDA inspections of drug and other regulated products. In an interview, Michael Leavitt, secretary of Health and Human Services, said China still has not solved all the problems it had with safety of items made for export to the United States, but "they moved aggressively to begin making progress." The first inspectors are to be placed in Beijing, Shanghai and Guangzhou, Leavitt said, but added he does not expect many future problems with Chinese-made drugs and other products. (Click here for more